生命科学资讯

Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale

10x Genomics (TXG) reports earnings tomorrow: What to expect - MSN

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - TradingView

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - The Chronicle-Journal

Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug

Simplifying library prep: All in a day’s work for Louise Fraser - Illumina

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Isomorphic claims major advance with new AI drug design engine

ILiAD raises $115M round to advance whooping cough vaccine

AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fight

NIH stops low-dose Xarelto arm of large stroke study due to safety concerns

Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study

Financings for Feb. 10, 2026

In the clinic for Feb. 10, 2026

Other news to note for Feb. 10, 2026

Regulatory actions for Feb. 10, 2026

Pharma company, execs charged with securities fraud

Is AstraZeneca on track to meet its $80B revenue target?

FDA rejects Regenxbio treatment in another blow to gene therapy

Waters Corporation (WAT): Guggenheim Reiterates 'Buy' Rating wit - GuruFocus